New Drug Approvals – Pt. XXIII – Romidepsin (Istodax) (ChEMBL)

Approved on November 5th 2009 was Romidepsin (trade name Istodax). Romidepsin, previously known by the research codes FK-228, FR-901228 and NSC-630176, is a histone deacetylase (HDAC) inhibitor indicated for the treatment of cutaneous T-cell lymphoma (CTCL)…

Read the full story here...

Reactor headlines and excerpts on the Reactive Reports chemistry blog are brought to you courtesy of the excellent Chemical Blogspace latest posts feed. You can subscribe directly to the Cb site here to receive updates on chemistry news, lab talk, and much more from a wide range of chemistry bloggers covering all the chemical sciences.

If you're lucky, the following quote may be relevant in some way to the post above, but then again...

Religion is regarded by the common people as true, by the wise as false, and by rulers as useful.
 - Lucius Annaeus Seneca (the Younger)

Drug users know their stuff

(University College London) Drug users are well informed about the harms associated with the drugs they use, and perceive alcohol and tobacco to be amongst the most dangerous substances, according to a survey by UCL and Imperial College London researchers. The findings, published in the Journal of Psychopharmacology, suggest that the current system of classifying psychoactive drugs in the UK may need to be revisited.

Read the full story here...

EurekAlert offers several feeds for breaking science news headlines. As part of the Reactive Reports chemistry news aggregation service, otherwise known as Reactor, we offer the chemistry, materials, nano and related feed here for RR readers. You can find out more about Eurekalert here.

If you're lucky, the following quote may be relevant in some way to the post above, but then again...

My mind shall not be disturbed; no angry word shall escape my lips; I will remain kind and friendly, with loving thoughts and no secret spite.
 - Siddhartha Gautama

University of Minnesota invention will help speed development of drug treatments for heart failure

(University of Minnesota) Research conducted by University of Minnesota scientists, in collaboration with Celladon Corporation, has led to the invention of technology to more rapidly identify compounds for the treatment of heart failure.

Read the full story here...

EurekAlert offers several feeds for breaking science news headlines. As part of the Reactive Reports chemistry news aggregation service, otherwise known as Reactor, we offer the chemistry, materials, nano and related feed here for RR readers. You can find out more about Eurekalert here.

If you're lucky, the following quote may be relevant in some way to the post above, but then again...

Take away love, and our earth is a tomb.
 - Robert Browning